We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

32 hedge funds and large institutions have $19.6M invested in Annovis Bio in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% less ownership

Funds ownership: 14.08% → 13.78% (-0.3%)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

16% less funds holding

Funds holding: 38 → 32 (-6)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

46% less capital invested

Capital invested by funds: $36.2M → $19.6M (-$16.6M)

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.02M
2
BlackRock
BlackRock
New York
+$1.14M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$866K
4
Citadel Advisors
Citadel Advisors
Florida
+$565K
5
BAM
Blueshift Asset Management
New Jersey
+$423K

Top Sellers

Rank Fund Capital Flow
1
Voloridge Investment Management
Voloridge Investment Management
Florida
-$2.21M
2
ACM
AIGH Capital Management
Maryland
-$2.11M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.18M
4
WVP
Worth Venture Partners
New Jersey
-$631K
5
VF
Virtu Financial
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.03M -$8.48K -329 -0.1%
Morgan Stanley
2
Morgan Stanley
New York
$2.72M +$3.02M +117,015 +308%
BlackRock
3
BlackRock
New York
$2.6M +$1.14M +44,269 +43%
Millennium Management
4
Millennium Management
New York
$1.18M +$39.3K +1,525 +2%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$1.12M +$866K +33,600 +111%
Citadel Advisors
6
Citadel Advisors
Florida
$1.04M +$565K +21,925 +59%
Two Sigma Investments
7
Two Sigma Investments
New York
$910K -$1.18M -45,819 -47%
WFAG
8
Wescott Financial Advisory Group
Pennsylvania
$731K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$719K – – –
MWM
10
Modera Wealth Management
New Jersey
$568K -$25.4K -985 -3%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$543K +$125K +4,867 +19%
BCM
12
Bridgeway Capital Management
Texas
$415K – – –
Voloridge Investment Management
13
Voloridge Investment Management
Florida
$406K -$2.21M -85,622 -79%
BAM
14
Blueshift Asset Management
New Jersey
$289K +$423K +16,418 New
State Street
15
State Street
Massachusetts
$288K – – –
SIAP
16
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$254K – – –
KCM
17
Knoll Capital Management
Florida
$250K – – –
Bank of America
18
Bank of America
North Carolina
$214K -$137K -5,327 -30%
CSS
19
Cubist Systematic Strategies
Connecticut
$206K +$303K +11,743 New
EL
20
Essex LLC
Illinois
$186K -$35.3K -1,369 -11%
Renaissance Technologies
21
Renaissance Technologies
New York
$185K +$271K +10,500 New
Goldman Sachs
22
Goldman Sachs
New York
$181K +$265K +10,273 New
CC
23
Cannell & Co
New York
$176K -$160K -6,200 -38%
Wells Fargo
24
Wells Fargo
California
$155K -$25.8K -1,000 -10%
Osaic Holdings
25
Osaic Holdings
Arizona
$152K -$62.1K -2,408 -22%
1
2

ANVS Hedge Fund Activity: Q4 2021 in Review

32 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2021, worth a combined $19.6M — down 46% from $36.2M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ANVS and 8 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $3.02M. The largest seller was Voloridge Investment Management, cutting an estimated $2.21M.

  • 32 institutional investors held Annovis Bio (ANVS) as of Q4 2021, down from 38 in Q3 2021.
  • Funds reported $19.6M of Annovis Bio stock for Q4 2021, down 46% quarter-over-quarter.
  • 8 funds opened new Annovis Bio positions in Q4 2021 and 14 closed out, a net change of -6 holders.
  • The largest Annovis Bio buyer in Q4 2021 was Morgan Stanley, an estimated $3.02M added.
  • The largest Annovis Bio seller in Q4 2021 was Voloridge Investment Management, an estimated $2.21M sold.

Based on aggregated 13F filings for Q4 2021.